GSK plc Director Hal Barron Acquires ADS Shares Through Dividend Reinvestment

GSK plc filed a Form 6-K reporting a transaction by Dr. Hal Barron, a Non-Executive Director, who acquired 74 American Depositary Shares (ADS) through dividend reinvestment in his GSK 401(k) plan account. The transaction occurred on May 15, 2026, at a price of $49.67 per share on the New York Stock Exchange. This is an initial notification of the transaction, which is a routine acquisition through dividend reinvestment rather than a market purchase. The filing demonstrates compliance with disclosure requirements for PDMR transactions and shows continued investment by a board member in the company's securities. Such filings are standard for tracking insider transactions and maintaining transparency about director holdings.